Scientists probe Hormone's role in diabetes and fatty liver
NCT ID NCT05500586
Summary
This study aims to understand how the hormone glucagon works in the liver and how this process might be different in people with obesity, type 2 diabetes, or fatty liver disease. Researchers will measure how the body processes amino acids with and without glucagon in a small group of participants. The goal is to gather knowledge about the underlying biology of these conditions, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.